结果页面 2，板块：医疗保健，行业：药品制造商 – 仿制药，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- BSE (10)
- Budapest (1)
- Buenos Aires (12)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (39)
- Helsinki (2)
- HKSE (1)
- IOB (15)
- Istanbul (1)
- KSE (3)
- Mexico (14)
- Milan (1)
- Munich (1)
- NSE (8)
- NYSE (6)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (4)
- Paris (2)
- Santiago (4)
- São Paulo (13)
- SES (1)
- Shanghai (3)
- Shenzhen (4)
- Stockholm (1)
- Swiss (5)
- Taipei Exchange (1)
- Tech Market Large (4)
- Tech Market Small (1)
- Tokyo (7)
- Vienna (13)
- XETRA (11)
医疗保健 (218)
- {{item.name}}
- 所有版块
- 医疗保健 (218)
药品制造商 – 仿制药 (218)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Merck & Co., Inc. MRCK34.SA | R$69.99 14.19 USD |
+0.16
|
R$1.39T 281.83B USD | R$462.00 93.64 USD | R$69.81 14.15 USD | R$69.99 14.19 USD | R$1.39T 281.83B USD | 13.40 | R$5.22 1.06 USD | ||
| AstraZeneca PLC AZNCF | $181.23 — |
+0.38
|
$280.96B — | $1.00 — | $187.68 — | $187.68 — | $280.96B — | 30.10 | $6.02 — | ||
| Gilead Sciences, Inc. GILD.BA | ARS 48,700.00 57.57 USD |
+3.31
|
ARS 230.32T 272.25B USD | ARS 0.00 0 USD | ARS 0.00 0 USD | ARS 0.00 0 USD | ARS 230.32T 272.25B USD | 5.19 | ARS 9.37K 11.07 USD | ||
| Merck & Co., Inc. MRK.MX | MX$1,836.67 108.75 USD |
0
|
MX$4.56T 269.93B USD | MX$0.00 0 USD | MX$1,836.67 108.75 USD | MX$1,836.67 108.75 USD | MX$4.56T 269.93B USD | 13.49 | MX$136.10 8.06 USD | ||
| AstraZeneca PLC ZEG.F | €155.35 169.82 USD |
+0.06
|
€240.84B 263.27B USD | €264.00 288.59 USD | €155.35 169.82 USD | €156.30 170.86 USD | €240.84B 263.27B USD | 30.22 | €5.14 5.62 USD | ||
| AstraZeneca PLC ZEGA.F | €77.00 84.17 USD |
0
|
€238.74B 260.98B USD | €2.32K 2.54K USD | €77.00 84.17 USD | €77.00 84.17 USD | €238.74B 260.98B USD | 30.07 | €2.56 2.8 USD | ||
| Pfizer Inc. PFE.BA | ARS 9,775.00 11.55 USD |
+0.62
|
ARS 220.52T 260.66B USD | ARS 617.00 0.73 USD | ARS 9,720.00 11.49 USD | ARS 9,965.00 11.78 USD | ARS 220.52T 260.66B USD | 1.95 | ARS 4.99K 5.9 USD | ||
| Merck & Co., Inc. MRK.SN | $102.40 — |
0
|
$254.16B — | $0.00 — | $102.40 — | $102.40 — | $254.16B — | 13.54 | $7.56 — | ||
| Novartis AG NOTA.F | €113.50 124.07 USD |
+0.44
|
€217.78B 238.07B USD | €570.00 623.09 USD | €113.50 124.07 USD | €113.50 124.07 USD | €217.78B 238.07B USD | 18.18 | €6.24 6.82 USD | ||
| Merck & Co., Inc. MRK.VI | €86.00 94.01 USD |
-0.58
|
€216.28B 236.42B USD | €7.00 7.65 USD | €86.00 94.01 USD | €86.10 94.12 USD | €216.28B 236.42B USD | 13.35 | €6.44 7.04 USD | ||
| Merck & Co., Inc. 6MK.DE | €85.80 93.79 USD |
-0.58
|
€215.77B 235.87B USD | €1.34K 1.46K USD | €85.50 93.46 USD | €86.40 94.45 USD | €215.77B 235.87B USD | 13.30 | €6.45 7.05 USD | ||
| Merck & Co., Inc. 6MK.F | €85.80 93.79 USD |
-1.15
|
€214.61B 234.6B USD | €309.00 337.78 USD | €85.80 93.79 USD | €86.20 94.23 USD | €214.61B 234.6B USD | 13.30 | €6.45 7.05 USD | ||
| Amgen Inc. AMGN.MX | MX$6,200.01 367.12 USD |
0
|
MX$3.40T 201.4B USD | MX$0.00 0 USD | MX$6,200.01 367.12 USD | MX$6,200.01 367.12 USD | MX$3.40T 201.4B USD | 26.66 | MX$232.50 13.77 USD | ||
| Amgen Inc. AMGN34.SA | R$64.84 13.14 USD |
0
|
R$977.85B 198.19B USD | R$0.00 0 USD | R$64.84 13.14 USD | R$64.84 13.14 USD | R$977.85B 198.19B USD | 25.42 | R$2.55 0.52 USD | ||
| Bristol-Myers Squibb Company BMY.BA | ARS 28,080.00 33.19 USD |
+2.26
|
ARS 164.34T 194.25B USD | ARS 38.00 0.04 USD | ARS 27,800.00 32.86 USD | ARS 28,140.00 33.26 USD | ARS 164.34T 194.25B USD | 6.51 | ARS 4.31K 5.09 USD | ||
| GSK plc GSK.BA | ARS 18,920.00 22.36 USD |
+1.18
|
ARS 152.66T 180.45B USD | ARS 0.00 0 USD | ARS 0.00 0 USD | ARS 0.00 0 USD | ARS 152.66T 180.45B USD | 14.66 | ARS 1.29K 1.53 USD | ||
| Gilead Sciences, Inc. GILD34.SA | R$331.77 67.24 USD |
0
|
R$824.90B 167.19B USD | R$0.00 0 USD | R$331.77 67.24 USD | R$331.77 67.24 USD | R$824.90B 167.19B USD | 18.58 | R$17.85 3.62 USD | ||
| Amgen Inc. AMGN.VI | €278.65 304.6 USD |
-1.15
|
€150.05B 164.02B USD | €0.00 0 USD | €278.65 304.6 USD | €279.45 305.48 USD | €150.05B 164.02B USD | 25.28 | €11.02 12.05 USD | ||
| Amgen Inc. AMG.DE | €277.25 303.07 USD |
-1.6
|
€149.29B 163.2B USD | €78.00 85.26 USD | €277.25 303.07 USD | €278.45 304.38 USD | €149.29B 163.2B USD | 25.15 | €11.02 12.05 USD | ||
| Amgen Inc. AMG.F | €276.95 302.74 USD |
-1
|
€149.13B 163.02B USD | €21.00 22.96 USD | €276.95 302.74 USD | €282.10 308.37 USD | €149.13B 163.02B USD | 25.13 | €11.02 12.05 USD | ||
| Gilead Sciences, Inc. GILD.MX | MX$2,190.62 129.71 USD |
0
|
MX$2.73T 161.47B USD | MX$0.00 0 USD | MX$2,190.62 129.71 USD | MX$2,190.62 129.71 USD | MX$2.73T 161.47B USD | 18.83 | MX$116.32 6.89 USD | ||
| Pfizer Inc. PFIZ34.SA | R$34.90 7.07 USD |
-0.26
|
R$793.72B 160.87B USD | R$618.00 125.26 USD | R$34.52 7 USD | R$34.97 7.09 USD | R$793.72B 160.87B USD | 14.66 | R$2.38 0.48 USD | ||
| Pfizer Inc. PFE.SN | $27.75 — |
+6.49
|
$157.78B — | $0.00 — | $27.75 — | $27.75 — | $157.78B — | 16.13 | $1.72 — | ||
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1.00 — | $0.00 — | $0.00 — | $157.63B — | 19.38 | $14.84 — | ||
| Pfizer Inc. PFE.MX | MX$453.25 26.84 USD |
-0.22
|
MX$2.58T 152.82B USD | MX$0.00 0 USD | MX$453.25 26.84 USD | MX$453.25 26.84 USD | MX$2.58T 152.82B USD | 14.63 | MX$30.98 1.83 USD | ||
| Gilead Sciences, Inc. GILD.VI | €105.86 115.72 USD |
-1.14
|
€132.46B 144.79B USD | €0.00 0 USD | €105.70 115.54 USD | €105.86 115.72 USD | €132.46B 144.79B USD | 19.24 | €5.50 6.01 USD | ||
| Gilead Sciences, Inc. GIS.DE | €105.62 115.46 USD |
-1.47
|
€131.46B 143.71B USD | €139.00 151.95 USD | €105.62 115.46 USD | €105.84 115.7 USD | €131.46B 143.71B USD | 19.16 | €5.51 6.02 USD | ||
| Gilead Sciences, Inc. GIS.F | €105.76 115.61 USD |
-0.41
|
€131.21B 143.43B USD | €16.00 17.49 USD | €105.76 115.61 USD | €106.00 115.87 USD | €131.21B 143.43B USD | 19.19 | €5.51 6.02 USD | ||
| Gilead Sciences, Inc. GILD.SN | $110.29 — |
-0.13
|
$136.83B — | $0.00 — | $110.29 — | $110.29 — | $136.83B — | 17.07 | $6.46 — | ||
| Pfizer Inc. PFE.VI | €21.53 23.53 USD |
-0.28
|
€122.38B 133.78B USD | €4.00 4.37 USD | €21.53 23.53 USD | €21.57 23.57 USD | €122.38B 133.78B USD | 14.64 | €1.47 1.61 USD | ||
| Pfizer Inc. PFEB.F | €6.80 7.43 USD |
+0.74
|
€122.06B 133.43B USD | €861.00 941.19 USD | €6.80 7.43 USD | €6.80 7.43 USD | €122.06B 133.43B USD | 13.59 | €0.50 0.55 USD | ||
| AstraZeneca PLC AZN.BA | ARS 70,975.00 83.89 USD |
+0.75
|
ARS 110.03T 130.06B USD | ARS 0.00 0 USD | ARS 0.00 0 USD | ARS 0.00 0 USD | ARS 110.03T 130.06B USD | 8.13 | ARS 8.73K 10.32 USD | ||
| Bristol-Myers Squibb Company BMYB34.SA | R$295.92 59.98 USD |
0
|
R$608.46B 123.32B USD | R$0.00 0 USD | R$295.92 59.98 USD | R$295.92 59.98 USD | R$608.46B 123.32B USD | 18.05 | R$16.39 3.32 USD | ||
| Bristol-Myers Squibb Company BMY.MX | MX$977.70 57.89 USD |
0
|
MX$1.99T 117.85B USD | MX$0.00 0 USD | MX$977.70 57.89 USD | MX$977.70 57.89 USD | MX$1.99T 117.85B USD | 18.28 | MX$53.48 3.17 USD | ||
| GSK plc G1SK34.SA | R$54.30 11.01 USD |
+1.5
|
R$547.66B 111B USD | R$100.00 20.27 USD | R$54.30 11.01 USD | R$54.30 11.01 USD | R$547.66B 111B USD | 13.81 | R$3.93 0.8 USD | ||
| Sanofi SNW.F | €81.78 89.4 USD |
-1.42
|
€99.85B 109.15B USD | €270.00 295.15 USD | €81.78 89.4 USD | €83.10 90.84 USD | €99.85B 109.15B USD | 15.60 | €5.24 5.73 USD | ||
| Sanofi SNW2.F | €40.80 44.6 USD |
+0.49
|
€99.84B 109.14B USD | €20.00 21.86 USD | €40.80 44.6 USD | €40.80 44.6 USD | €99.84B 109.14B USD | 15.57 | €2.62 2.86 USD | ||
| Sanofi SANO.VI | €81.89 89.52 USD |
-0.09
|
€99.50B 108.77B USD | €50.00 54.66 USD | €81.80 89.42 USD | €82.36 90.03 USD | €99.50B 108.77B USD | 15.62 | €5.24 5.73 USD | ||
| Bristol-Myers Squibb Company BRM.F | €46.47 50.8 USD |
+1.44
|
€94.60B 103.41B USD | €75.00 81.99 USD | €46.06 50.34 USD | €46.47 50.8 USD | €94.60B 103.41B USD | 18.36 | €2.53 2.77 USD | ||
| GSK plc GSKN.MX | MX$864.00 51.16 USD |
0
|
MX$1.74T 103.2B USD | MX$0.00 0 USD | MX$864.00 51.16 USD | MX$864.00 51.16 USD | MX$1.74T 103.2B USD | 13.47 | MX$64.11 3.8 USD | ||
| Bristol-Myers Squibb Company BMYS.VI | €46.30 50.61 USD |
+0.13
|
€94.27B 103.05B USD | €0.00 0 USD | €46.11 50.4 USD | €46.30 50.61 USD | €94.27B 103.05B USD | 18.29 | €2.53 2.77 USD | ||
| Bristol-Myers Squibb Company BRM.DE | €46.19 50.49 USD |
-0.11
|
€94.09B 102.85B USD | €1.73K 1.89K USD | €46.00 50.28 USD | €46.24 50.55 USD | €94.09B 102.85B USD | 18.25 | €2.53 2.77 USD | ||
| GSK GLAXF | $24.03 — |
+1.35
|
$99.11B — | $1.30K — | $23.66 — | $23.71 — | $99.11B — | 13.50 | $1.78 — | ||
| Chugai Pharmaceutical CHGCF | $52.15 — |
-1.04
|
$90.82B — | $500.00 — | $52.05 — | $52.18 — | $90.82B — | 33.86 | $1.54 — | ||
| Chugai Pharmaceutical Co., Ltd. CUP.F | €43.95 48.04 USD |
-0.95
|
€73.10B 79.91B USD | €345.00 377.13 USD | €43.95 48.04 USD | €44.03 48.13 USD | €73.10B 79.91B USD | 33.29 | €1.32 1.44 USD | ||
| Biogen Inc. BIIB.BA | ARS 20,970.00 24.79 USD |
+3.5
|
ARS 38.32T 45.29B USD | ARS 98.00 0.12 USD | ARS 0.00 0 USD | ARS 20,970.00 24.79 USD | ARS 38.32T 45.29B USD | 1.31 | ARS 15.91K 18.8 USD | ||
| Bayer Aktiengesellschaft BAYZF | $41.80 — |
+1.11
|
$41.83B — | $1.18K — | $41.65 — | $42.00 — | $41.83B — | 0 | -$0.23 — | ||
| Bayer Aktiengesellschaft BAYA.F | €9.05 9.89 USD |
+5.23
|
€35.56B 38.88B USD | €1.58K 1.72K USD | €8.80 9.62 USD | €9.15 10 USD | €35.56B 38.88B USD | 0 | -€0.05 -0.05 USD | ||
| Bayer Aktiengesellschaft BAYN.VI | €35.58 38.89 USD |
-0.06
|
€34.96B 38.22B USD | €1.01K 1.11K USD | €35.57 38.88 USD | €35.85 39.18 USD | €34.96B 38.22B USD | 0 | -€0.20 -0.2 USD | ||
| Bayer Aktiengesellschaft BAYER.BD | HUF 13,828.00 38.24 USD |
-0.29
|
HUF 13.61T 37.64B USD | HUF 2.02K 5.58 USD | HUF 13,760.00 38.06 USD | HUF 13,868.00 38.35 USD | HUF 13.61T 37.64B USD | 0 | -HUF 77.65 -0.2 USD | ||
| Daiichi Sankyo Company, Limited D4S.F | €17.99 19.67 USD |
-1.53
|
€33.30B 36.4B USD | €1.60K 1.75K USD | €17.54 19.17 USD | €17.99 19.67 USD | €33.30B 36.4B USD | 21.93 | €0.82 0.9 USD | ||
| Otsuka Holdings Co., Ltd. OS1.F | €48.20 52.69 USD |
-4.55
|
€26.33B 28.78B USD | €26.00 28.42 USD | €48.20 52.69 USD | €48.20 52.69 USD | €26.33B 28.78B USD | 11.55 | €4.17 4.56 USD | ||
| Biogen Inc. BIIB34.SA | R$157.04 31.83 USD |
0
|
R$138.78B 28.13B USD | R$0.00 0 USD | R$157.04 31.83 USD | R$157.04 31.83 USD | R$138.78B 28.13B USD | 15.59 | R$10.07 2.04 USD | ||
| Biogen Inc. BIIB.MX | MX$3,125.00 185.04 USD |
0
|
MX$458.44B 27.15B USD | MX$0.00 0 USD | MX$3,125.00 185.04 USD | MX$3,125.00 185.04 USD | MX$458.44B 27.15B USD | 15.82 | MX$197.50 11.69 USD | ||
| Biogen Inc. IDP.F | €150.15 164.13 USD |
+4.71
|
€22.17B 24.23B USD | €280.00 306.08 USD | €147.75 161.51 USD | €150.15 164.13 USD | €22.17B 24.23B USD | 16.05 | €9.35 10.22 USD | ||
| Biogen Inc. IDP.DE | €150.55 164.57 USD |
+1.62
|
€22.09B 24.14B USD | €63.00 68.87 USD | €148.15 161.95 USD | €150.55 164.57 USD | €22.09B 24.14B USD | 16.08 | €9.36 10.23 USD | ||
| Biogen Inc. BIIB.VI | €149.40 163.31 USD |
+0.74
|
€21.92B 23.96B USD | €0.00 0 USD | €149.40 163.31 USD | €151.00 165.06 USD | €21.92B 23.96B USD | 15.99 | €9.34 10.21 USD | ||
| Astellas Pharma ALPMF | $13.00 — |
-0.38
|
$23.93B — | $100.00 — | $13.10 — | $13.10 — | $23.93B — | 28.88 | $0.45 — | ||
| Astellas Pharma Inc. YPH.F | €11.11 12.14 USD |
-1.33
|
€20.47B 22.37B USD | €375.00 409.93 USD | €11.11 12.14 USD | €11.11 12.14 USD | €20.47B 22.37B USD | 29.22 | €0.38 0.42 USD | ||
| Astellas Pharma Inc. YPHA.F | €11.00 12.02 USD |
-0.9
|
€20.29B 22.18B USD | €176.00 192.39 USD | €11.00 12.02 USD | €11.00 12.02 USD | €20.29B 22.18B USD | 28.94 | €0.38 0.42 USD | ||
| Cipla Limited CIPLA.BO | ₹1,512.50 18.3 USD |
-0.3
|
₹1.22T 14.78B USD | ₹78.44K 948.99 USD | ₹1,508.25 18.25 USD | ₹1,523.70 18.43 USD | ₹1.22T 14.78B USD | 22.45 | ₹67.35 0.81 USD | ||
| Orion Oyj ORINF | $81.30 — |
0
|
$11.44B — | $100.00 — | $81.30 — | $81.30 — | $11.44B — | 26.05 | $3.12 — | ||
| CSPC Pharmaceutical Group Limited CVG.F | €0.88 0.97 USD |
+0.05
|
€10.33B 11.29B USD | €2.50K 2.73K USD | €0.88 0.97 USD | €0.88 0.97 USD | €10.33B 11.29B USD | 22.07 | €0.04 0.04 USD | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | €48.24 52.73 USD |
+0.5
|
€9.88B 10.81B USD | €0.00 0 USD | €48.16 52.65 USD | €48.28 52.78 USD | €9.88B 10.81B USD | 24.99 | €1.93 2.11 USD | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | €48.06 52.54 USD |
+0.42
|
€9.87B 10.79B USD | €30.00 32.79 USD | €47.64 52.08 USD | €48.14 52.62 USD | €9.87B 10.79B USD | 24.90 | €1.93 2.11 USD | ||
| Orion Oyj ORINY | $35.28 — |
0
|
$9.93B — | $1.00 — | $34.10 — | $34.10 — | $9.93B — | 26.93 | $1.31 — | ||
| Orion Oyj OFK0.F | €31.00 33.89 USD |
+1.97
|
€8.90B 9.73B USD | €100.00 109.31 USD | €31.00 33.89 USD | €31.00 33.89 USD | €8.90B 9.73B USD | 27.67 | €1.12 1.22 USD | ||
| Orion Oyj OFK.F | €61.95 67.72 USD |
+0.08
|
€8.74B 9.55B USD | €11.00 12.02 USD | €61.95 67.72 USD | €61.95 67.72 USD | €8.74B 9.55B USD | 27.78 | €2.23 2.44 USD | ||
| Grifols, S.A. GIKLY | $6.16 — |
0
|
$8.38B — | $50.00 — | $6.70 — | $6.70 — | $8.38B — | 19.25 | $0.32 — | ||
| Kyowa Kirin KYKOF | $15.85 — |
0
|
$8.29B — | $1.40K — | $16.54 — | $16.54 — | $8.29B — | 33.71 | $0.47 — | ||
| Grifols, S.A. GIFOF | $8.25 — |
-6.41
|
$8.11B — | $4.41K — | $8.18 — | $8.25 — | $8.11B — | 15.86 | $0.52 — | ||
| Grifols, S.A. OZTA.F | €10.89 11.9 USD |
+0.14
|
€7.41B 8.1B USD | €1.09K 1.19K USD | €10.89 11.9 USD | €10.89 11.9 USD | €7.41B 8.1B USD | 19.80 | €0.55 0.6 USD | ||
| Grifols, S.A. GRF.VI | €10.88 11.89 USD |
+1.16
|
€7.40B 8.09B USD | €0.00 0 USD | €10.88 11.89 USD | €10.99 12.01 USD | €7.40B 8.09B USD | 19.78 | €0.55 0.6 USD | ||
| Grifols GIFLF | $11.66 — |
0
|
$7.93B — | $500.00 — | $14.00 — | $14.00 — | $7.93B — | 18.21 | $0.64 — | ||
| Grifols, S.A. G0F.F | €5.20 5.68 USD |
+1.96
|
€7.08B 7.74B USD | €160.00 174.9 USD | €5.20 5.68 USD | €5.20 5.68 USD | €7.08B 7.74B USD | 19.25 | €0.27 0.3 USD | ||
| Kyowa Kirin Co., Ltd. KY4.F | €13.30 14.54 USD |
-2.21
|
€7.01B 7.66B USD | €500.00 546.57 USD | €13.30 14.54 USD | €13.40 14.65 USD | €7.01B 7.66B USD | 33.25 | €0.40 0.44 USD | ||
| Grifols, S.A. G0FB.F | €7.60 8.31 USD |
+2.01
|
€6.60B 7.22B USD | €5.00 5.47 USD | €7.60 8.31 USD | €7.60 8.31 USD | €6.60B 7.22B USD | 13.81 | €0.55 0.6 USD | ||
| Abbott India Limited ABBOTINDIA.BO | ₹28,004.70 338.81 USD |
-0.12
|
₹595.08B 7.2B USD | ₹282.00 3.41 USD | ₹27,855.05 337 USD | ₹28,134.60 340.38 USD | ₹595.08B 7.2B USD | 39.47 | ₹709.39 8.58 USD | ||
| Ono Pharmaceutical OPHLF | $13.28 — |
0
|
$6.44B — | $104.00 — | $12.22 — | $12.22 — | $6.44B — | 18.44 | $0.72 — | ||
| Ono Pharmaceutical Co., Ltd. ON4.MU | €11.80 12.9 USD |
-0.84
|
€5.63B 6.15B USD | €0.00 0 USD | €11.80 12.9 USD | €11.80 12.9 USD | €5.63B 6.15B USD | 19.34 | €0.61 0.67 USD | ||
| Ono Pharmaceutical Co., Ltd. ON4.F | €11.40 12.46 USD |
-0.87
|
€5.44B 5.94B USD | €41.00 44.82 USD | €11.40 12.46 USD | €11.50 12.57 USD | €5.44B 5.94B USD | 18.68 | €0.61 0.67 USD | ||
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS | ₹2,523.40 30.53 USD |
-0.22
|
₹427.48B 5.17B USD | ₹54.17K 655.39 USD | ₹2,519.90 30.49 USD | ₹2,550.10 30.85 USD | ₹427.48B 5.17B USD | 44.74 | ₹56.40 0.68 USD | ||
| GlaxoSmithKline Pharmaceuticals Limited GLAXO.BO | ₹2,523.30 30.53 USD |
-0.45
|
₹427.46B 5.17B USD | ₹2.59K 31.38 USD | ₹2,506.75 30.33 USD | ₹2,550.75 30.86 USD | ₹427.46B 5.17B USD | 44.84 | ₹56.27 0.68 USD | ||
| PT Kalbe Farma Tbk PTKFF | $0.07 — |
0
|
$3.54B — | $185.00K — | $0.08 — | $0.08 — | $3.54B — | 0 | $0.00 — | ||
| Gland Pharma Limited GLAND.BO | ₹1,689.70 20.44 USD |
+1.12
|
₹278.39B 3.37B USD | ₹2.67K 32.31 USD | ₹1,675.10 20.27 USD | ₹1,691.75 20.47 USD | ₹278.39B 3.37B USD | 35.23 | ₹47.96 0.58 USD | ||
| Gland Pharma Limited GLAND.NS | ₹1,687.40 20.41 USD |
+0.94
|
₹278.01B 3.36B USD | ₹62.49K 756.02 USD | ₹1,672.30 20.23 USD | ₹1,691.70 20.47 USD | ₹278.01B 3.36B USD | 35.16 | ₹47.98 0.58 USD | ||
| Virbac SA 0NM7.IL | €347.25 379.59 USD |
+0.07
|
€2.96B 3.23B USD | €64.00 69.96 USD | €346.00 378.22 USD | €347.25 379.59 USD | €2.96B 3.23B USD | 24.82 | €13.99 15.29 USD | ||
| Virbac SA VIRP.PA | €347.00 379.32 USD |
-0.72
|
€2.91B 3.18B USD | €888.00 970.7 USD | €343.00 374.95 USD | €350.50 383.14 USD | €2.91B 3.18B USD | 21.86 | €15.87 17.35 USD | ||
| Virbac SA V16.F | €339.50 371.12 USD |
-0.15
|
€2.84B 3.11B USD | €2.00 2.19 USD | €339.50 371.12 USD | €343.00 374.95 USD | €2.84B 3.11B USD | 21.37 | €15.88 17.36 USD | ||
| Santen Pharmaceutical SNPHF | $9.51 — |
0
|
$3.06B — | $200.00 — | $12.46 — | $12.64 — | $3.06B — | 15.84 | $0.60 — | ||
| Santen Pharmaceutical Co., Ltd. SZD.F | €8.65 9.46 USD |
-1.14
|
€2.78B 3.04B USD | €23.00 25.14 USD | €8.65 9.46 USD | €8.65 9.46 USD | €2.78B 3.04B USD | 16.96 | €0.51 0.56 USD | ||
| Pfizer Limited PFIZER.BO | ₹5,090.50 61.59 USD |
-0.17
|
₹233.15B 2.82B USD | ₹2.13K 25.82 USD | ₹5,006.20 60.57 USD | ₹5,140.00 62.19 USD | ₹233.15B 2.82B USD | 27.73 | ₹183.57 2.22 USD | ||
| Pfizer Limited PFIZER.NS | ₹5,093.10 61.62 USD |
-0.09
|
₹233.00B 2.82B USD | ₹17.39K 210.41 USD | ₹5,050.10 61.1 USD | ₹5,130.00 62.06 USD | ₹233.00B 2.82B USD | 27.75 | ₹183.51 2.22 USD | ||
| Haw Par Corporation Limited HAWPY | $50.80 — |
0
|
$2.81B — | $1.00 — | $46.37 — | $46.37 — | $2.81B — | 14.63 | $3.47 — | ||
| Haw Par HAWPF | $10.66 — |
0
|
$2.36B — | $100.00 — | $10.62 — | $10.62 — | $2.36B — | 12.11 | $0.88 — | ||
| Johnson & Johnson DJNJ2.BA | ARS 815.00 0.96 USD |
0
|
ARS 1.96T 2.32B USD | ARS 0.00 0 USD | ARS 815.00 0.96 USD | ARS 815.00 0.96 USD | ARS 1.96T 2.32B USD | 13.25 | ARS 61.49 0.07 USD | ||
| Cosmo Pharmaceuticals CMOPF | $130.61 — |
+2.52
|
$2.32B — | $100.00 — | $123.50 — | $123.50 — | $2.32B — | 31.24 | $4.18 — | ||
| Organon & Co. OGN.MX | MX$126.40 7.48 USD |
-0.13
|
MX$32.86B 1.95B USD | MX$0.00 0 USD | MX$126.40 7.48 USD | MX$126.40 7.48 USD | MX$32.86B 1.95B USD | 3.67 | MX$34.38 2.04 USD | ||
| Cosmo Pharmaceuticals N.V. C43.F | €108.00 118.06 USD |
-0.92
|
€1.74B 1.9B USD | €10.00 10.93 USD | €107.00 116.97 USD | €108.00 118.06 USD | €1.74B 1.9B USD | 30.33 | €3.56 3.89 USD | ||
| Organon & Co. 7XP.F | €5.79 6.33 USD |
-0.38
|
€1.50B 1.64B USD | €653.00 713.82 USD | €5.78 6.32 USD | €5.79 6.33 USD | €1.50B 1.64B USD | 3.55 | €1.63 1.78 USD | ||
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
|||||||||||
- {{ link.label }} {{link}}